The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 7,001–7,100 of 31,469
Francis, E. C., Li, M., Hinkle, S. N., Cao, Y., Chen, J., Wu, J., Zhu, Y., Cao, H., Kemper, K., Rennert, L., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001333 · Cited by 53
Toussirot, É., Marotte, H., Mulleman, D., Cormier, G., Coury, F., Gaudin, P., Dernis, E., Bonnet, C., Damade, R., Grauer, J.-L., et al. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-02297-7 · Cited by 51
Zeeshan, M., Zhang, Y.-T., Yu, S., Huang, W.-Z., Zhou, Y., Vinothkumar, R., Chu, C., Li, Q.-Q., Wu, Q.-Z., Ye, W.-L., et al. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2021.130486 · Cited by 51
Fatty Acid Esters of Hydroxy Fatty Acids (FAHFAs) Are Associated With Diet, BMI, and Age
Kellerer, T., Kleigrewe, K., Brandl, B., et al. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.691401 · Cited by 51
Sexual violence and cardiovascular disease risk: A systematic review and meta-analysis
Jakubowski, K., Murray, V., Stokes, N., & Thurston, R. C. (2021) · Maturitas · doi:10.1016/j.maturitas.2021.07.014 · Cited by 59
Atzeni, A., Bastiaanssen, T. F. S., Cryan, J. F., Tinahones, F. J., Vioqué, J., Corella, D., Fitó, M., Vidal, J., Moreno‐Indias, I., Gómez‐Pérez, A. M., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.804455 · Cited by 50
Signatures of muscle disuse in spaceflight and bed rest revealed by single muscle fiber proteomics
Murgia, M., Ciciliot, S., Nagaraj, N., Reggiani, C., Schiaffino, S., Franchi, M. V., Pišot, R., Šimunič, B., Toniolo, L., Blaauw, B., et al. (2022) · PNAS Nexus · doi:10.1093/pnasnexus/pgac086 · Cited by 53
Tan, D., Tseng, H. H. L., Zhong, Z., Wang, S., Vong, C. T., & Wang, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231910988 · Cited by 55
Seo, Y., Pοlyzos, S. A., Park, K., & Mantzoros, C. S. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.04.026 · Cited by 54
Jiang, S., Liu, A., Ma, W., Liu, X., Luo, P., Zhan, M., Zhou, X., Chen, L., & Zhang, J. (2023) · Food & Function · doi:10.1039/d3fo01701j · Cited by 53
ADAMS-HUET, B. A., Zubirán, R., Remaley, A. T., & Jialal, I. (2024) · Journal of clinical lipidology · doi:10.1016/j.jacl.2024.04.130 · Cited by 52
Chen, X., Li, A., & Ma, Q. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02599-7 · Cited by 53
Abuelo, Á., Bermúdez, J. H., Benedito, J. L., & Castillo, C. (2015) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.12365 · Cited by 53
Kurdoğlu, Z., Özkol, H., Tülüce, Y., & Koyuncu, İ. (2012) · PubMed · doi:10.3275/7682 · Cited by 51
Ormseth, M. J., Lipson, A., Alexopoulos, N. A., Hartlage, G. R., Oeser, A. M., Bian, A., Gebretsadik, T. S., Shintani, A., Raggi, P., & Stein, C. M. (2013) · Arthritis Care & Research · doi:10.1002/acr.22027 · Cited by 50
Daka, B., Langer, R. D., Larsson, C., Rosén, T., Jansson, P. A., Råstam, L., & Lindblad, U. (2015) · BMC Endocrine Disorders · doi:10.1186/s12902-015-0034-1 · Cited by 48
Circulating Betatrophin Is Strongly Increased in Pregnancy and Gestational Diabetes Mellitus
Trebotic, L. K., Klimek, P., Thomas, A., Fenzl, A., Leitner, K., Springer, S., Kiefer, F. W., & Kautzky‐Willer, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136701 · Cited by 52
Resaland, G. K., Anderssen, S. A., Holme, I., Mamen, A., & Andersen, L. B. (2010) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/j.1600-0838.2010.01181.x · Cited by 54
Yoon, K., Shockey, G., Teng, R., Golm, G. T., Thakkar, P., Meehan, A. G., Williams‐Herman, D., Kaufman, K. D., Amatruda, J. M., & Steinberg, H. O. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02589.x · Cited by 51
Hepatic Steatosis and Thyroid Function Tests in Overweight and Obese Children
Pacifico, L., Bonci, E., Ferraro, F., Andreoli, G., Bascetta, S., & Chiesa, C. (2013) · International Journal of Endocrinology · doi:10.1155/2013/381014 · Cited by 51
Dietary glycemic index and risk of type 2 diabetes mellitus in middle-aged Japanese men
Sakurai, M., Nakamura, K., Miura, K., Takamura, T., Yoshita, K., Morikawa, Y., Ishizaki, M., Kido, T., Naruse, Y., Suwazono, Y., et al. (2011) · Metabolism · doi:10.1016/j.metabol.2011.05.015 · Cited by 51
Rull, A., Geeraert, B., Aragonès, G., Beltrán‐Debón, R., Rodríguez‐Gallego, E., García‐Heredia, A., Pedro‐Botet, J., Joven, J., Holvoet, P., & Camps, J. (2014) · Journal of Proteome Research · doi:10.1021/pr401230s · Cited by 51
Lin, Y., Chang, P., Chang, M., & Ni, Y. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.046417 · Cited by 52
Abbasi, F., Okeke, Q., & Reaven, G. M. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0461-2 · Cited by 53
Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndrome
Köninger, A., Koch, L., Edimiris, P., Enekwe, A., Nagarajah, J., Kasimir‐Bauer, S., Kimmig, R., Strowitzki, T., & Schmidt, B. (2014) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-014-3317-2 · Cited by 51
Madsen, M. A., Krusenstjerna-Hafstrøm, T., Møller, L. F., Christensen, B., Vendelbo, M. H., Pedersen, S. B., Frystyk, J., Jessen, N., Hansen, T. K., Stødkilde‐Jørgensen, H., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2681 · Cited by 49
Sweet craving and ghrelin and leptin levels in women during stress
Macedo, D. M., & Garcia, R. W. D. (2014) · Appetite · doi:10.1016/j.appet.2014.05.031 · Cited by 52
Nordstrand, N., Gjevestad, E. S., Hertel, J. K., Johnson, L. K., Saltvedt, E., Røislien, J., & Hjelmesaeth, J. S. (2013) · Obesity · doi:10.1002/oby.20099 · Cited by 51
Sex-Specific Association of Fetuin-A With Type 2 Diabetes in Older Community-Dwelling Adults
Laughlin, G. A., Barrett-Connor, E. L., Cummins, K. M., Daniels, L. B., Wassel, C. L., & Ix, J. H. (2013) · Diabetes Care · doi:10.2337/dc12-1870 · Cited by 51
Esposito, K., Palo, C. D., Maiorino, M. I., Petrizzo, M., Bellastella, G., Siniscalchi, I., & Giugliano, D. (2010) · Cardiology Research and Practice · doi:10.4061/2011/293916 · Cited by 51
Koçer, D., Bayram, F., & Diri, H. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.887063 · Cited by 51
Jung, J., & Kim, H. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.07.048 · Cited by 51
Association between Dietary Patterns and Insulin Resistance in Mexican Children and Adolescents
Romero-Polvo, A., Denova‐Gutiérrez, E., Rivera‐Paredez, B., et al. (2012) · Annals of Nutrition and Metabolism · doi:10.1159/000341493 · Cited by 51
Relationship between obesity and metabolic syndrome among Argentinean elementary school children
Hirschler, V., Oestreicher, K., Maccallini, G., & Aranda, C. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.11.003 · Cited by 50
Doknić, M., Marić, N. P., Britvić, D., Pekić, S., Damjanović, A., Miljić, D., Stojanović, M. D. M., Radojicic, Z. A., Gašić, M. J., & POPOVIC, V. M. (2011) · Neuroendocrinology · doi:10.1159/000329391 · Cited by 52
High Blood Pressure, Bone-Mineral Loss and Insulin Resistance in Women
GOTOH, M., Mizuno, K., Yoshiaki, O. N. O., et al. (2005) · Hypertension Research · doi:10.1291/hypres.28.565 · Cited by 51
Nakanishi, S., Yamane, K., Ohishi, W., Nakashima, R., Yoneda, M., Nojima, H., Watanabe, H., & Kohno, N. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.06.003 · Cited by 51
Application of alternative anthropometric measurements to predict metabolic syndrome
Sağun, G., Oğuz, A., Karagoz, E., Filizer, A. T., Tamer, G. I., & Mesçi, B. (2014) · Clinics · doi:10.6061/clinics/2014(05)09 · Cited by 51
He, C., Lee, C.-H., Hsieh, C., Hsiao, F., Kuo, P., Chu, N., & Hung, Y. (2014) · International Journal of Endocrinology · doi:10.1155/2014/657607 · Cited by 51
He, J., Reilly, M. P., Yang, W. P., Chen, J., Go, A. S., Lash, J. P., Rahman, M., deFilippi, C. R., Gadegbeku, C. A., Kanthety, R., et al. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.07.044 · Cited by 49
Isolated Impaired Fasting Glucose and Peripheral Insulin Sensitivity
Kim, S. H., & Reaven, G. M. (2008) · Diabetes Care · doi:10.2337/dc07-1574 · Cited by 53
Goropashnaya, A. V., Herron, J., Sexton, M., Havel, P. J., Stanhope, K. L., Plaetke, R., Mohatt, G. V., & Boyer, B. B. (2008) · Metabolism · doi:10.1016/j.metabol.2008.09.002 · Cited by 52
Cardiovascular disease, SCI and exercise: unique risks and focused countermeasures
Cowan, R. E., & Nash, M. S. (2010) · Disability and Rehabilitation · doi:10.3109/09638288.2010.491579 · Cited by 52
Tastesen, H. S., Keenan, A. H., Madsen, L., Kristiansen, K., & Liaset, B. (2014) · Amino Acids · doi:10.1007/s00726-014-1715-1 · Cited by 51
Vascular risk in women with a history of severe preeclampsia
Göynümer, G., Yücel, N., Adalı, E., et al. (2012) · Journal of Clinical Ultrasound · doi:10.1002/jcu.21962 · Cited by 51
Circulating Adiponectin Is Associated with Obesity and Serum Lipids in West Africans
Meilleur, K. G., Doumatey, A. P., Huang, H., Charles, B. A., Chen, G., Zhou, J., Shriner, D., Adeyemo, A., & Rotimi, C. N. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2765 · Cited by 51
Dittrich, R., Kajaia, N., Cupisti, S., Hoffmann, I., Beckmann, M. W., & Mueller, A. (2009) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60165-4 · Cited by 51
Son, J. W., Kim, M., Park, Y., Baek, K., Yoo, S.-J., Song, K., Son, H. S., Yoon, K., Lee, W. C., Cha, B., et al. (2010) · Endocrine Journal · doi:10.1507/endocrj.k10e-248 · Cited by 51
Association of Retinol-Binding Protein-4 (RBP4) with Lipid Parameters in Obese Women
Broch, M., Gómez, J. M., Auguet, T., Vilarrasa, N., Pastor, R., Elío, I., Olona, M., García‐España, A., & Richart, C. (2010) · Obesity Surgery · doi:10.1007/s11695-010-0200-5 · Cited by 50
Tůmová, E., Sun, W., Jones, P. H., Vrablı́k, M., Ballantyne, C. M., & Hoogeveen, R. C. (2013) · Journal of Obesity · doi:10.1155/2013/729515 · Cited by 52
Negrato, C. A., Jovanovič, L., Tambascia, M. A., Calderon, I. D. M. P., Geloneze, B., Días, A., & Rudge, M. V. C. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.815 · Cited by 50
The effect of insulin on circulating PCSK9 in postmenopausal obese women
Awan, Z. A., Dubuc, G., Faraj, M., Dufour, R., Seidah, N. G., Davignon, J., RABASA-LHORET, R. P. R., & Baass, A. W. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.03.022 · Cited by 55
Effect of walking exercise on abdominal fat, insulin resistance and serum cytokines in obese women
Hong, H.-R., Jeong, J., Kong, J., Lee, S. S., Yang, S.-H., Ha, C., & Kang, H. (2014) · Physical Activity and Nutrition · doi:10.5717/jenb.2014.18.3.277 · Cited by 51
Effects of Age on Insulin Resistance and Secretion in Subjects without Diabetes
Oya, J., Nakagami, T., Yamamoto, Y., Fukushima, S., Takeda, M., Endo, Y., & Uchigata, Y. (2014) · Internal Medicine · doi:10.2169/internalmedicine.53.1580 · Cited by 53
Wang, J., Persuitte, G. M., Olendzki, B. C., Wedick, N. M., Zhang, Z., Merriam, P. A., Fang, H., Carmody, J., Olendzki, G.-F., & Ma, Y. (2013) · Nutrients · doi:10.3390/nu5103910 · Cited by 51
Comparison of prognostic variables in children and adults with Fontan circulation
Ohuchi, H., Yasuda, K., Miyazaki, A., Iwasa, T., Sakaguchi, H., Ono, S., Mizuno, M., Negishi, J., Noritake, K., & Yamada, O. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.03.001 · Cited by 51
Yarasheski, K. E., Laciny, E., Overton, E. T., Reeds, D. N., Harrod, M., Baldwin, S., & Dávila‐Román, V. G. (2012) · Journal of Inflammation · doi:10.1186/1476-9255-9-26 · Cited by 51
St-Pierre, D., Faraj, M., Karelis, A. D., Conus, F., Henry, J., St-Onge, M., Tremblay-Lebeau, A., Cianflone, K., & RABASA-LHORET, R. P. R. (2006) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70259-8 · Cited by 52
Lebensztejn, D. M., Wojtkowska, M., Skiba, E., et al. (2009) · Advances in Medical Sciences · doi:10.2478/v10039-009-0047-y · Cited by 51
Imbalanced circulating matrix metalloproteinases in polycystic ovary syndrome
Gomes, V. A., Vieira, C. S., Jacob‐Ferreira, A. L., Belo, V. D. A., Soares, G. M., Fernandes, J. B. F., Ferriani, R. A., & Tanus-Santos, J. E. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0793-6 · Cited by 51
Dickerson, E. H., Cho, L., Maguiness, S. D., Killick, S. R., Robinson, J., & Atkin, S. L. (2009) · Human Reproduction · doi:10.1093/humrep/dep393 · Cited by 51
Westermeier, F., Salomón, C., Farías, M., Arroyo, P., Fuenzalida, B., Sáez, T., Salsoso, R., Sanhueza, C., Guzmán‐Gutiérrez, E., Pardo, F., et al. (2014) · The FASEB Journal · doi:10.1096/fj.14-254219 · Cited by 52
Schultes, B., Ernst, B., Schmid, F., & Thurnheer, M. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0079 · Cited by 52
Kanety, H., Hemi, R., Ginsberg, S., Pariente, C., Yissachar, E., Barhod, E., Funahashi, T., & Laron, Z. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0419 · Cited by 49
HOMA-IR and the risk of hyperuricemia: A prospective study in non-diabetic Japanese men
Nakamura, K., Sakurai, M., Miura, K., Morikawa, Y., Nagasawa, S., Ishizaki, M., Kido, T., Naruse, Y., Nakashima, M., Nogawa, K., et al. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.07.006 · Cited by 49
Can a Dairy-Rich Diet Be Effective in Long-Term Weight Control of Young Children?
Kelishadi, R., Zemel, M. B., Hashemipour, M., Hosseini, M., Mohammadifard, N., & Poursafa, P. (2009) · Journal of the American College of Nutrition · doi:10.1080/07315724.2009.10719792 · Cited by 51
Putative role for insulin resistance in depression risk in polycystic ovary syndrome
Greenwood, E. A., Pasch, L. A., Shinkai, K., Cedars, M. I., & Huddleston, H. G. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.05.019 · Cited by 51
Bennet, L., Johansson, S., Agardh, C., Groop, L., Sundquist, J., Råstam, L., & Sundquist, K. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-303 · Cited by 51
Lu, C., Ivaska, K. K., Alén, M., Wang, Q., Törmäkangas, T., Xu, L., Wiklund, P., Mikkola, T. M., Pekkala, S., Tian, H., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2045 · Cited by 49
Tilves, C., Zmuda, J. M., Kuipers, A. L., Nestlerode, C. S., Evans, R. G., Bunker, C. H., Patrick, A. L., & Miljkovic, I. (2015) · Diabetes Care · doi:10.2337/dc15-1777 · Cited by 51
Effects of Hormone Replacement Therapy on Insulin Resistance in Postmenopausal Diabetic Women
Bitoska, I., Krstevska, B., Milenković, T., Šubeska-Stratrova, S., Petrovski, G., Mishevska, S. J., Ahmeti, I., & Todorova, B. (2016) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2016.024 · Cited by 51
Reduced β-cell function in early preclinical type 1 diabetes
Koskinen, M. K., Helminen, O., Matomäki, J., Aspholm, S., Mykkänen, J., Mäkinen, M., Simell, V., Vähä-Mäkilä, M., Simell, T. T., Ilonen, J., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0674 · Cited by 51
Beneficial Effect of Betulinic Acid on Hyperglycemia via Suppression of Hepatic Glucose Production
Kim, S. J., Quan, H. Y., Jeong, K. J., Kim, D. Y., Kim, G. W., Jo, H. K., & Chung, S. H. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf4030739 · Cited by 52
Wu, S., Fisher‐Hoch, S. P., Reininger, B. M., & McCormick, J. B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152896 · Cited by 51
Pramfalk, C., Pavlides, M., Banerjee, R., McNeil, C. A., Neubauer, S., Karpe, F., & Hodson, L. (2016) · Diabetes · doi:10.2337/db16-0236 · Cited by 51
Furtado, C. L. M., Ramos, F. K. P., Kogure, G. S., Santana-Lemos, B. A. A., Ferriani, R. A., Calado, R. T., & dos Reis, R. M. (2016) · Reproductive Sciences · doi:10.1177/1933719115611753 · Cited by 52
Salazar, C. R., Strizich, G., Seeman, T. E., Isasi, C. R., Gallo, L. C., Avilés-Santa, L. M., Cai, J., Penedo, F. J., Argüelles, W., Sanders, A. E., et al. (2016) · SSM - Population Health · doi:10.1016/j.ssmph.2016.05.003 · Cited by 53
High Serum Irisin Level as an Independent Predictor of Diabetes Mellitus
Huh, J. H., Ahn, S. V., Choi, J. H., Koh, S. B., & Chung, C. H. (2016) · Medicine · doi:10.1097/md.0000000000003742 · Cited by 51
Kim, S. R., Lee, Y., Lee, S., Kang, E. S., Soo, B., Kim, J., & Lee, B. (2016) · Medicine · doi:10.1097/md.0000000000004114 · Cited by 55
Chun, Y., Xiaoqiang, L., Mao, Y., et al. (2016) · Journal of Biomedical Research · doi:10.7555/jbr.30.20140111 · Cited by 51
Non-Alcoholic Fatty Liver Disease: Cause or Effect of Metabolic Syndrome
Grander, C., Grabherr, F., Moschen, A. R., & Tilg, H. (2016) · Visceral Medicine · doi:10.1159/000448940 · Cited by 56
Oh, T. J., Lim, S. K., Kim, K. M., Moon, J. H., Choi, S. H., Cho, Y. M., Park, K. S., Jang, H. C., & Cho, N. H. (2016) · Clinical Endocrinology · doi:10.1111/cen.13280 · Cited by 51
Lee, A. M., Fermin, C. R., Filipp, S. L., Gurka, M. J., & DeBoer, M. D. (2017) · Acta Diabetologica · doi:10.1007/s00592-016-0958-6 · Cited by 52
Metabolic Manifestations of Hepatitis C Virus
Serfaty, L. (2017) · Clinics in Liver Disease · doi:10.1016/j.cld.2017.03.004 · Cited by 51
Nobili, V., Alisi, A., Mosca, A., Corte, C. D., Veraldi, S., Vito, R. D., Stefanis, C. D., Doria, V., Jahnel, J., Zöhrer, E., et al. (2017) · Liver International · doi:10.1111/liv.13531 · Cited by 53
Kong, S. H., Park, Y. J., Lee, J., Cho, N. H., & Moon, M. K. (2018) · Scientific Reports · doi:10.1038/s41598-017-18998-0 · Cited by 52
Zhang, Y., Meng, F., Sun, X., Sun, X., Hu, M., Cui, P., Vestin, E., Li, X., Li, W., Wu, X., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24477 · Cited by 52
Maltais, A., Alméras, N., Lemieux, I., Tremblay, A., Bergeron, J., Poirier, P., & Després, J. (2018) · Metabolism · doi:10.1016/j.metabol.2018.04.003 · Cited by 51
Air pollution: A public health approach for Portugal
Torres, P. N. L. R., Ferreira, J., Monteiro, A., Costa, S., Pereira, M. D. C., Madureira, J., Mendes, A., & Teixeira, J. P. (2018) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2018.06.281 · Cited by 54
Choi, D., Jung, C., Mok, J., Kim, C., Kang, S.-K., & Kim, B. (2018) · Endocrinology and Metabolism · doi:10.3803/enm.2018.33.3.387 · Cited by 50
Wang, R., Yang, F., Li, Q., Huang, R., Liu, Q., & Li, X. (2018) · Clinical Obesity · doi:10.1111/cob.12289 · Cited by 50
Pereira, S. S., Guimarães, M., Almeida, R., Pereira, A. M., Lobato, C. B., Hartmann, B., Hilsted, L., Holst, J. J., Nora, M. C., & Monteiro, M. P. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0282-z · Cited by 53
Abubakar, S. M., Ukeyima, M. T., Spencer, J. P. E., & Lovegrove, J. A. (2019) · Nutrients · doi:10.3390/nu11020341 · Cited by 55
Epigenome-wide association study in peripheral white blood cells involving insulin resistance
Arpón, A., Milagro, F. I., Ramos-López, O., Mansego, M. L., Santos, J. L., Riezu‐Boj, J. I., & Martínez, J. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-38980-2 · Cited by 52
Caro-Gómez, E., Sierra, J. A., Escobar, J. S., Álvarez, R., Naranjo, M., Medina, S., Velásquez-Mejía, E. P., Tabares-Guevara, J. H., Jaramillo, J. C., León-Varela, Y. M., et al. (2019) · Nutrients · doi:10.3390/nu11030497 · Cited by 55
Miranda, K., Mehrpouya‐Bahrami, P., Nagarkatti, P. S., & Nagarkatti, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01049 · Cited by 51
O’Donovan, S. D., Lenz, M., Goossens, G. H., Kallen, C., Eussen, S. J. P. M., Stehouwer, C. D. A., van Greevenbroek, M. M. J., Schram, M. T., Sep, S. J. S., Peeters, R., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-45858-w · Cited by 51
Oh, T. J., Lee, J.-E., Choi, S. H., & Jang, H. C. (2019) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes.2019.28.2.112 · Cited by 51
Sha, H., Zeng, H., Zhao, J. V., & Jin, H. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172522 · Cited by 51
Blanchard, A., Vallet, M., Dubourg, L. D., Hureaux, M., Allard, J., Haymann, J., de la Faille, R., Arnoux, A., Dinut, A., Bergerot, D., et al. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019010031 · Cited by 53
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
